Yan-Mei Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yan-Mei Liu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Lingqin Ni
Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China
2 shared publicationsShenpeng Ying
Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China
2 shared publicationsDe Li
Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China
1 shared publicationJilin Xu
Department of Radiation Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China
1 shared publication- Jin-Ye Xu
Department of Breast and Thyroid Surgery, Taizhou Municipal Hospital, Taizhou, 318000, Zhejiang, China.
1 shared publication - Ling-Qin Ni
Department of Radiation Oncology, Tai Zhou Central Hospital, Tai Zhou, Zhe Jiang, 318000, China
1 shared publication
Latest Publications
- Open Access
- 12 December 2025
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
A dosimetric correlation between the bladder filling volume and its effects on radiation dose during high-dose-rate intracavitary brachytherapy in patients with cervical cancer
Background The purpose of this study was to establish a dosimetric correlation between the bladder filling volume and its effects on the dose received by the organs at risk (OARs) (bladder, rectum, sigmoid colon and small intestine) during computed tomography (CT)-guided high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer and to determine the optimized bladder filling volume. Methodology In this retrospective study, the dosimetric parameters of 230 cervical cancer patients (stage IIa, IIb, IIIa, IIIb, IIIc, and IV) treated with external beam radiotherapy followed by CT-guided HDR-ICBT at our institute between June 2021 and September 2023 were studied. Results The dose-volume histogram (DVH) parameters of the bladder increased with increasing volume of the bladder. The minimum dose to the bladder was observed when the bladder volume was less than 80 ml. The minimum dose to the small intestine was recorded when the bladder volume was greater than 120 ml. The correlations between the bladder volume and the doses received by the rectum and the sigmoid were not statistically significant. Conclusion There is a relationship between the bladder filling volume and the dose received by the bladder and small intestine. A bladder filling volume of approximately 80 ml or less was well tolerated and achieved a reasonably reproducible bladder volume during cervical brachytherapy, although small intestine doses are lower with greater bladder filling volumes.
- 12 December 2025
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Open AccessA dosimetric correlation between the bladder filling volume and its effects on radiation dose during high-dose-rate intracavitary brachytherapy in patients with cervical cancer
Background The purpose of this study was to establish a dosimetric correlation between the bladder filling volume and its effects on the dose received by the organs at risk (OARs) (bladder, rectum, sigmoid colon and small intestine) during computed tomography (CT)-guided high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer and to determine the optimized bladder filling volume. Methodology In this retrospective study, the dosimetric parameters of 230 cervical cancer patients (stage IIa, IIb, IIIa, IIIb, IIIc, and IV) treated with external beam radiotherapy followed by CT-guided HDR-ICBT at our institute between June 2021 and September 2023 were studied. Results The dose-volume histogram (DVH) parameters of the bladder increased with increasing volume of the bladder. The minimum dose to the bladder was observed when the bladder volume was less than 80 ml. The minimum dose to the small intestine was recorded when the bladder volume was greater than 120 ml. The correlations between the bladder volume and the doses received by the rectum and the sigmoid were not statistically significant. Conclusion There is a relationship between the bladder filling volume and the dose received by the bladder and small intestine. A bladder filling volume of approximately 80 ml or less was well tolerated and achieved a reasonably reproducible bladder volume during cervical brachytherapy, although small intestine doses are lower with greater bladder filling volumes.
- Open Access
- 23 February 2023
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 21 (1) , 1-10
Individualized estimates of intensity-modulated radiotherapy plans after breast conservation surgery for left-sided breast cancer
The purpose of this study was to explore the influence of individual patient factors, such as volume of the planning target volume (PTV) (VPTV), cardiothoracic ratio (CTR), central lung distance (CLD), and maximal heart distance (MHD), on the design of treatment plans in terms of target dose coverage, integral dose, and dose to organs at risk (OAR) in early breast cancer. Ninety-six patients were selected for this study. Radiation doses of 50 Gy and a simultaneous dose of 60 Gy in 25 fractions were administered to the whole breast and tumor bed, respectively. The intensity modulation plan (IMRT) of each patient uses both physical parameters and an equivalent uniform dose (EUD) to optimize the target function. Univariate and multivariate linear regression were used to analyze the relationship between predictive impact factors and OAR percent dose volume, conformity index (CI), and homogeneity index (HI). The average CI and HI values of the left breast cancer plan were 0.595 ± 0.071 (0.3–0.72) and 1.095 ± 0.023 (1.06–1.18), respectively. The CTR (B = 0.21, P = 0.045), VPTV (B = 0.63, P = 0.000), volume of the lung (Vlung) (B = − 0.29, P = 0.005), and MHD (B = 0.22, P = 0.041) were identified as factors influencing the CI index of the left breast cancer intensity modulation plan. VPTV (B = 1.087, P = 0.022) was identified as the influencing factor of the HI index of the left breast cancer intensity modulation plan. volume of the heart (Vheart) (B = − 0.43, P = 0.001) and CLD (B = 0.28, P = 0.008) were influencing factors of the volume of lung (Vlung20) of the lung. The prediction formulas for left-sided breast cancer are noted as follows: CI = 0.459 + 0.19CTR-0.16CLD, Vlung10 = 35.5–0.02Vheart; and Vlung20 = 21.48 + 2.8CLD-0.018Vheart. CTR, CLD, and MHD can predict the rationality of the parameters of the left breast cancer IMRT. The calculation formula generated based on this information can help the physicist choose the optimal radiation field setting method and improve the quality of the treatment plan.
- 23 February 2023
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 21 (1) , 1-10
Open AccessIndividualized estimates of intensity-modulated radiotherapy plans after breast conservation surgery for left-sided breast cancer
The purpose of this study was to explore the influence of individual patient factors, such as volume of the planning target volume (PTV) (VPTV), cardiothoracic ratio (CTR), central lung distance (CLD), and maximal heart distance (MHD), on the design of treatment plans in terms of target dose coverage, integral dose, and dose to organs at risk (OAR) in early breast cancer. Ninety-six patients were selected for this study. Radiation doses of 50 Gy and a simultaneous dose of 60 Gy in 25 fractions were administered to the whole breast and tumor bed, respectively. The intensity modulation plan (IMRT) of each patient uses both physical parameters and an equivalent uniform dose (EUD) to optimize the target function. Univariate and multivariate linear regression were used to analyze the relationship between predictive impact factors and OAR percent dose volume, conformity index (CI), and homogeneity index (HI). The average CI and HI values of the left breast cancer plan were 0.595 ± 0.071 (0.3–0.72) and 1.095 ± 0.023 (1.06–1.18), respectively. The CTR (B = 0.21, P = 0.045), VPTV (B = 0.63, P = 0.000), volume of the lung (Vlung) (B = − 0.29, P = 0.005), and MHD (B = 0.22, P = 0.041) were identified as factors influencing the CI index of the left breast cancer intensity modulation plan. VPTV (B = 1.087, P = 0.022) was identified as the influencing factor of the HI index of the left breast cancer intensity modulation plan. volume of the heart (Vheart) (B = − 0.43, P = 0.001) and CLD (B = 0.28, P = 0.008) were influencing factors of the volume of lung (Vlung20) of the lung. The prediction formulas for left-sided breast cancer are noted as follows: CI = 0.459 + 0.19CTR-0.16CLD, Vlung10 = 35.5–0.02Vheart; and Vlung20 = 21.48 + 2.8CLD-0.018Vheart. CTR, CLD, and MHD can predict the rationality of the parameters of the left breast cancer IMRT. The calculation formula generated based on this information can help the physicist choose the optimal radiation field setting method and improve the quality of the treatment plan.
- Open Access
- 29 January 2018
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 16 (1) , 18
Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study
The objective of this study is to analyze the treatment outcome and secondary reactions in 98 patients with stage I–III cervical carcinoma who underwent postoperative radiotherapy. From 2006 to 2014, 98 patients with stage I–III cervical carcinoma were treated with postoperative radiotherapy. The major histological type, found in 92.86% of the patients (91 cases), was squamous cell carcinoma. Patients were staged according to the 2002 TNM guidelines. The postoperative radiotherapy methods included two-field irradiation (16 patients, 16.32%), four-field box irradiation (16 patients, 16.32%), and intensity-modulated radiotherapy (IMRT; 66 patients, 67.36%). The survival rates were represented using Kaplan-Meier curves, and prognosis analyses were performed using Cox multivariate analyses. The 5-year overall survival and progression-free survival rates were 82.0 and 76.0%, respectively. Only one patient (1.02%) developed a grade 3 acute radiation enteritis, while grade 3 and 4 myelosuppression was noted in 17 patients (17.35%) and one patient (1.02%), respectively. Multivariate analyses showed that anemia before radiotherapy and tumor size were predictors of the OS (P = 0.008, P = 0.045) rates. Postoperative radiotherapy for patients with risk factors of cervical cancer procured good efficacy levels with mild side effects. Anemia and tumor size were important OS predictors.
- 29 January 2018
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 16 (1) , 18
Open AccessOutcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study
The objective of this study is to analyze the treatment outcome and secondary reactions in 98 patients with stage I–III cervical carcinoma who underwent postoperative radiotherapy. From 2006 to 2014, 98 patients with stage I–III cervical carcinoma were treated with postoperative radiotherapy. The major histological type, found in 92.86% of the patients (91 cases), was squamous cell carcinoma. Patients were staged according to the 2002 TNM guidelines. The postoperative radiotherapy methods included two-field irradiation (16 patients, 16.32%), four-field box irradiation (16 patients, 16.32%), and intensity-modulated radiotherapy (IMRT; 66 patients, 67.36%). The survival rates were represented using Kaplan-Meier curves, and prognosis analyses were performed using Cox multivariate analyses. The 5-year overall survival and progression-free survival rates were 82.0 and 76.0%, respectively. Only one patient (1.02%) developed a grade 3 acute radiation enteritis, while grade 3 and 4 myelosuppression was noted in 17 patients (17.35%) and one patient (1.02%), respectively. Multivariate analyses showed that anemia before radiotherapy and tumor size were predictors of the OS (P = 0.008, P = 0.045) rates. Postoperative radiotherapy for patients with risk factors of cervical cancer procured good efficacy levels with mild side effects. Anemia and tumor size were important OS predictors.
- Open Access
- 1 December 2015
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 30
Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
The aim of this study was to detect the expression of hypoxia-inducible factor (HIF)-1α and HIF-2α in papillary thyroid carcinoma (PTC) compared with normal thyroid tissues. The mRNA levels and protein levels of HIF-1α and HIF-2α were detected by real-time PCR and Western blot separately in 30 pairs of PTCs and normal thyroid cases. The protein levels were also detected by immunohistochemistry (IHC) using 92 samples of PTC group and 46 normal samples as control group for analyzing the biological and clinical significance of the expression of HIF-1α/HIF-2α. Real-time PCR results showed the mRNA level of HIF-1α and HIF-2α were significantly higher in PTC than normal group (P < 0.001). Also, significantly higher positive rates (73 %/65 %) of HIF-1α and HIF-2α were observed in PTC compared with the control group (27 %/35 %) by IHC (P < 0.01); the consistent results were gotten with Western blot. Although we did not find a significant correlation between the expression of HIF-1α and HIF-2α with gender, age, calcification, or Hashimoto’s disease in the present study (P > 0.05), both of their expressions were correlated to lymph node metastasis (P < 0.05), capsular invasion (P < 0.05), and TNM stage (P < 0.05). Overexpression of HIF-1α and HIF-2α are associated with the carcinogenesis of PTC, served as potential biomarkers of PTC.
- 1 December 2015
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 30
Open AccessExpression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
The aim of this study was to detect the expression of hypoxia-inducible factor (HIF)-1α and HIF-2α in papillary thyroid carcinoma (PTC) compared with normal thyroid tissues. The mRNA levels and protein levels of HIF-1α and HIF-2α were detected by real-time PCR and Western blot separately in 30 pairs of PTCs and normal thyroid cases. The protein levels were also detected by immunohistochemistry (IHC) using 92 samples of PTC group and 46 normal samples as control group for analyzing the biological and clinical significance of the expression of HIF-1α/HIF-2α. Real-time PCR results showed the mRNA level of HIF-1α and HIF-2α were significantly higher in PTC than normal group (P < 0.001). Also, significantly higher positive rates (73 %/65 %) of HIF-1α and HIF-2α were observed in PTC compared with the control group (27 %/35 %) by IHC (P < 0.01); the consistent results were gotten with Western blot. Although we did not find a significant correlation between the expression of HIF-1α and HIF-2α with gender, age, calcification, or Hashimoto’s disease in the present study (P > 0.05), both of their expressions were correlated to lymph node metastasis (P < 0.05), capsular invasion (P < 0.05), and TNM stage (P < 0.05). Overexpression of HIF-1α and HIF-2α are associated with the carcinogenesis of PTC, served as potential biomarkers of PTC.